Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
VanEck Oil Services ETF
OIH
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
US Stock MarketDetailed Quotes
Cyclerion Therapeutics (CYCN)
- 2.940
- -0.010-0.34%
Close Apr 24 15:59 ET
- 2.820
- -0.120-4.08%
Post 20:01 ET
12.73MMarket Cap-2.65P/E (TTM)
3.010High2.872Low151.07KVolume2.910Open2.950Prev Close439.85KTurnover4.20%Turnover RatioLossP/E (Static)4.33MShares8.48052wk High1.40P/B10.57MFloat Cap1.02752wk Low--Dividend TTM3.59MShs Float420.000Historical High--Div Yield TTM4.68%Range %1.027Historical Low2.912Avg Price1Lot Size
Cyclerion Therapeutics (CYCN) Key Financial Indicators
CYCN Earnings per Share (EPS)
According to the latest financial report of Cyclerion Therapeutics, the latest earnings per share (TTM) for the company is -0.19. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
CYCN Free Cash Flow (FCF)
Interested in knowing about Cyclerion Therapeutics's free cash flow? The latest report shows it as -1.58M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
CYCN Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cyclerion Therapeutics shows that the company's current ratio is 5.15, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
CYCN Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cyclerion Therapeutics, the quick ratio is 4.71, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
CYCN Return on Equity (ROE)
Want to learn more about the financial health of Cyclerion Therapeutics? The latest ROE figure is -8.58%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
CYCN Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cyclerion Therapeutics, the total asset return on investment (ROA) is -7.83%.
Currency: USD
Quarterly
Loading...
CYCN Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cyclerion Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
CYCN Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cyclerion Therapeutics, the net profit margin is -77.95%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm